UPDATE: Goldman Sachs Downgrades Universal American Corporation to Sell on Medicare Advantage Risk
Posted on December 07, 2012 at 07:49 AM EST
Goldman Sachs reduced its rating on Universal American Corporation (NYSE: UAM ) from Neutral to Sell with an $8 price target. Goldman Sachs noted, "We downgrade Universal American to Sell from Neutral, reflecting our view of downside risk to earnings from its Medicare Advantage (MA) business given the scheduled